Cite

HARVARD Citation

    Rubbini, G. et al. (2018). Lead optimization-hit expansion of new asymmetrical pyridinium/quinolinium compounds as choline kinase α1 inhibitors. Future medicinal chemistry. pp. 1769-1786. [Online]. 
  
Back to record